Application of Transgenic Silk Fibroin to Biomaterials
Biotechnology and Bioengineering · 2026-08 · 123 (8) · 2192-2212
DOI: 10.1002/bit.70249 ↗At a glance
Übersichtsarbeit in Biotechnology and Bioengineering, published online on 2026-05-26. Written by Tetsuo Asakura and 3 co-authors. Institution: Department of Biotechnology, Tokyo University of Agriculture and Technology, Tokyo, Japan. Major MEDLINE topics: Fibroins, Biocompatible Materials, Bombyx, Animals, Genetically Modified. 151 references. The full text is freely available in PubMed Central. Funded by: Japan Society of Promotion of Science) KAKENHI.
Abstract (original language)
As a biomaterial, silk fibroin (SF) derived from the silkworm Bombyx mori exhibits excellent biocompatibility, controllable biodegradability, minimal inflammatory responses, outstanding mechanical properties, and high processability that enables the formation of various tailored morphologies. However, the properties of natural silk proteins alone may not satisfy all application requirements. To overcome these limitations, researchers have been modifying silk protein genes using genetic engineering and molecular biotechnology to produce novel SFs with specific functions. This approach has expanded the application range of SF and enhanced its overall value. Transgenic (TG) expression technology provides an effective means for functional modification of SF, significantly advancing its applications in biomedical and other fields. This review discusses recent structural studies of B. mori SF, along with the design, production, and validation of targeted TG SFs, as well as the latest developments in TG silk technology. Furthermore, it outlines the significance of TG SF development based on comparisons with conventional silk. In particular, it highlights the advantages of TG SF in wound dressing materials, bone regeneration, and the development of small‐diameter artificial vascular grafts. Lastly, we discussed the challenges and limitations that TG silk development currently faces.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biotechnology, Tokyo University of Agriculture and Technology, Tokyo, Japan.
- Department of Veterinary Surgery, Tokyo University of Agriculture and Technology, Tokyo, Japan.
- Institute of Agrobiological Sciences, National Agriculture and Food Research Organization, Ibaraki, Japan.
Funding
- Japan Society of Promotion of Science) KAKENHI
Cite
APA
Asakura, T., Tanaka, T., Tatematsu, K., & Sezutsu, H. (2026). Application of Transgenic Silk Fibroin to Biomaterials. Biotechnology and Bioengineering, 123(8), 2192-2212. https://doi.org/10.1002/bit.70249
Vancouver
Asakura T, Tanaka T, Tatematsu K, Sezutsu H. Application of Transgenic Silk Fibroin to Biomaterials. Biotechnology and Bioengineering. 2026;123(8):2192-2212. doi:10.1002/bit.70249
BibTeX
@article{Asakura2026,
author = {Asakura, Tetsuo and Tanaka, Takashi and Tatematsu, Kenichiro and Sezutsu, Hideki},
title = {Application of Transgenic Silk Fibroin to Biomaterials},
journal = {Biotechnology and Bioengineering},
year = {2026},
volume = {123},
number = {8},
pages = {2192--2212},
doi = {10.1002/bit.70249}
}
EUVIMED